NSE filing, NSE: DHARIWAL. Summary written from the filing by ALFA Finder's alert engine.
Dhariwalcorp Ltd: key numbers
- Share price
- ₹21.90
- Market cap
- ₹205.9 Cr
- Revenue (annual)
- ₹236.4 Cr
- Net profit (annual)
- ₹8.59 Cr
- P/E (TTM)
- 24.0×Sector 35.5×
- Promoter holding
- 64.22%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dhariwalcorp Ltd
All →Dhariwalcorp Preferential Issue
Dhariwalcorp's EGM approved the issue of 33,00,000 equity shares to the promoter on preferential basis. The proposed 1,70,01,000 convertible warrants were not approved.
Dhariwalcorp Preferential Issue
Dhariwalcorp's EGM on October 29, 2026 considered a preferential issue of 33,00,000 shares to the promoter and 1,70,01,000 warrants. Voting results will be reported separately.
Dhariwalcorp Annual General Meeting
Dhariwalcorp Limited announced an Extra-ordinary General Meeting (EGM) on October 29, 2026, to approve the preferential issuance of equity shares and warrants.
Dhariwalcorp Fund Raise of ₹8.63 Cr
Dhariwalcorp Limited will hold an EGM on October 29, 2026, to seek approval for a preferential issue of 33 lakh equity shares worth Rs. 8.63 Crore.
- Value
- ₹8.63 Cr
Dhariwalcorp Fund Raise of ₹53.07 Cr
Dhariwalcorp approved a preferential issue of 33 lakh equity shares and 1.7 crore convertible warrants, aggregating Rs 53.07 Crore, to promoters and other investors.
- Value
- ₹53.07 Cr
Dhariwalcorp Board Meeting Date
Dhariwalcorp Limited scheduled a board meeting for September 30, 2026, to discuss a proposed fund-raising plan through a preferential issue.
Other other announcement announcements
All →Neueon Corporation Other Announcement
Neueon Corporation's members approved amendments to its Articles of Association via postal ballot, now approved by the Registrar of Companies. The amendment allows the Board to make multiple calls on partly paid shares.
Balaxi Pharmaceuticals Other Announcement
Balaxi Pharmaceuticals filed its RTA report for October 2026 on re-lodgement of physical share transfers. All request counts for the month are NIL.
Leapfrog Engineering Services Other Announcement
Leapfrog Engineering received a Trade Mark registration certificate for building construction services in Class 37. The registration discloses no monetary value or business impact.
Quest Laboratories Other Announcement
Quest Laboratories reported no deviation in IPO fund utilisation for the half year ended September 2026. Its statement was reviewed by the Audit Committee.
Vinyas Innovative Technologies Other Announcement
Vinyas Innovative filed CRISIL's monitoring agency report for the quarter ended 30 September 2026. It reports no deviation from objects for its preferential warrant issue proceeds.
Parag Milk Foods Other Announcement
Sixth Sense India Opportunities III sold 43,842 shares on NSE for about Rs 1.45 Crore. Its stake fell from 1.44% to 1.40%.
- Value
- ₹1.45 Cr